Compare ClearPoint Neuro Inc (CLPT) vs Mongodb Inc (MDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Mongodb Inc — how do they compare? ClearPoint Neuro Inc trades at $15.22 (market cap $454.21M), while Mongodb Inc trades at $438.95 (market cap $35.32B). The key difference: Mongodb Inc is far larger — about 77.8× ClearPoint Neuro Inc's market cap, and Mongodb Inc is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | MDB | |
|---|---|---|
Market Cap | $454.21M | $35.32B |
Sector | Health | Technology |
52-Week High | $29.60 | $440.25 |
52-Week Low | $8.66 | $204.37 |
Enterprise Value | $488.79M | $32.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.20, up 4.32% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings estimates, with a net income margin of -81.76%. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology.
The outlook remains speculative with high growth potential in neurotherapy markets, but significant execution and profitability risks persist. Analyst consensus is unanimously bullish, though sustained losses and cash burn require careful monitoring for long-term investors.
MDB trades at $436.91, up 4.86% over the past day, with a bullish technical signal from moving averages and strong analyst sentiment. Revenue growth is robust, reaching $2.01B in 2025, though the company remains unprofitable with a net income margin of -1.12%. Recent earnings beats and an upcoming Q2 2026 report on September 1, 2026, highlight operational momentum amid high institutional interest.
The outlook is positive given consistent earnings outperformance and projected revenue growth to $2.6B in 2026. Risks include persistent losses, competitive pressures, and high valuation multiples. With 82% of analysts rating it a buy and a consensus price target of $404.30, the stock offers growth potential but requires monitoring of profitability trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
